Generics Makers Settle Liver Drug Patent Fight On Eve Of Trial
Intercept Pharmaceuticals, MSN Pharmaceuticals and Apotex told a Delaware federal judge that they've cut deals to end Intercept's claims that Apotex's proposed generic version of Ocaliva, treatment for a rare liver disease, infringes...To view the full article, register now.
Already a subscriber? Click here to view full article